|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Reproduction and Development Group, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts AL9 7TA
2 Centre for Developmental Origins of Health and Disease, University of Southampton, SO16 5YA, UK
| Abstract |
|---|
|
|
|---|
(Received 15 July 2004;
accepted after revision 27 October 2004;
first published online 28 October 2004)
Corresponding author DC Wathes: Reproduction and Development Group, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts AL9 7TA, UK. Email: dcwathes{at}rvc.ac.uk
| Introduction |
|---|
|
|
|---|
Polyunsaturated fats derived from the diet provide both energy and structural components of cell membranes. They also act as precursors for a variety of signalling molecules and thereby influence many fundamental cell processes. Linoleic acid is an essential fatty acid, which is metabolized to
-linolenic acid (GLA), dihomo-
-linolenic acid (DGLA, 20: 3 n-6) and arachidonic acid (AA, 20: 4 n-6) by position-specific
6 and
5 desaturases and CoA-dependent chain elongases (Sprecher, 2000). Cyclo-oxygenases (COX) catalyse the conversion of AA into 2-series prostaglandins (PGs); COX-1 is expressed constitutively and is relatively non-responsive to exogenous stimuli whereas COX-2 is inducible by a variety of agents (Smith et al. 1996).
In sheep, parturition is initiated by the fetus by increased activity or maturation of the hypothalamicpituitary adrenal (HPA) axis (Liggins & Thorburn, 1994; Lye et al. 1998; Challis et al. 2000). As a result, plasma adrenocorticotrophic hormone (ACTH) and cortisol concentrations rise progressively over the last 1520 days of pregnancy (Norman et al. 1985) and cause a shift in placental steroid production from progesterone to oestrogen which is due to increased expression of steroidogenic enzymes within the placenta (Ricketts et al. 1980). These changes in placental steroid production are accompanied by increases in the expression and activity of COX within uterine tissues (Challis et al. 1997), which are linked to increased prostaglandin output. PGE2 is produced primarily by the fetal component of the placentomes (Liggins & Thorburn, 1994). Rising concentrations of PGE2 over the last 3 weeks of gestation are important for various aspects of fetal maturation (Smith, 1998; Heyman, 1999). At term, PGE2 contributes to connective tissue remodelling associated with cervical dilatation and rupture of the fetal membranes (Liggins & Thorburn, 1994; Challis et al. 1997). Increased release of PGF2
only occurs in the final 1224 h before delivery, following up-regulation of COX-2 in the maternal endometrium, when PGF2
promotes myometrial contractions. COX-2 mRNA increases with both term and preterm labour, whereas COX-1 expression remains unchanged (McLaren et al. 1996; Challis et al. 1997; Challis et al. 2002).
Preterm birth occurs in about 10% of all human pregnancies and is a major cause of death and handicap in newborn babies (Goldenberg et al. 2000; Allen & Harris, 2001). The reasons for preterm delivery are in many cases unknown. There is previous evidence to suggest that both n-6 and n-3 PUFAs have the ability to alter the timing of parturition and length of gestation. Rats fed a diet deficient in linoleic acid had an increased gestation length and difficult parturitions; both these abnormalities were prevented by the addition of linoleic or arachidonic acid (Holman, 1971). Intravenous infusion of fish oil for 2 days in late gestational ewes was able to delay betamethasone-induced premature delivery (Baguma-Nibasheka et al. 1999). Increased gestation lengths also occur commonly in human populations that have a high habitual intake of fish in their diet, for example the Inuit of Greenland or women of the Faeroe Islands (Olsen et al. 1986, 1992). There is, however, little available information on the effect of a high n-6 PUFA diet on the timing of parturition and length of gestation. Excessive n-6 PUFA consumption by women in Western countries is relatively common and these fatty acids are known to have the ability to increase prostaglandin production (Smith et al. 1991). The objective of this study was thus to investigate the effect of feeding a diet supplemented with LA on the timing and onset of established labour, using the ewe as an experimental model.
| Methods |
|---|
|
|
|---|
All animal experiments were conducted under the UK Animal (Scientific Procedures) Act 1986 with local ethical committee approval. Mature multiparous Welsh Mountain ewes were mated following synchronization of oestrus. The mean gestation length in a contemporary group of untreated ewes was 145 ± 0.4 days (n= 7). Ewes carrying singleton pregnancies (confirmed by a mid-gestation ultrasound scan) were allocated to a control or LA-supplemented diet from 100 days gestation (day GA) onwards. Data were obtained from five control ewes and nine LA-supplemented ewes. The n-6 PUFA was fed as SoyPreme (Boregaard UK Ltd, Warrington, UK). SoyPreme is a heat-treated product of xylose and cracked soyabean (Abel-Caines et al. 1998). This reaction reduces the degradability of the protein and protects the PUFAs from biohydrogenation in the rumen. Each diet was based on a mixture of maize silage, grass silage and concentrates with added SoyPreme (170200 g day1) on the LA-supplemented diet only. The diets were formulated to be isonitrogenous and isoenergetic (Table 1). The actual amounts fed were calculated on an individual ewe basis (reviewed every 2 weeks) to meet the maintenance requirement of the ewe according to her weight and stage of gestation and were fed individually. The fatty acid analysis of the SoyPreme was: C16: 0 11%, C18: 0 4%, C18: 1n-9 cis 21%, C18: 2n-6 53% (LA), C18: 3n-3 cis (LNA) 8%, others < 1%. Based on (1) the PUFA content of the diets, (2) the lipid content of the diets and (3) the proportion of the PUFAs from SoyPreme (55%) compared with other dietary components (15%) expected to escape dehydrogenation, the amount of LA reaching the small intestine was estimated to be approximately 2.8 g day1 on the control diet and 11.8 g day1 on the LA-supplemented diet. There was also a small overall increase in the amount of LNA likely to reach the small intestine from 1.4 g on the control diet to 2.2 g on the SoyPreme diet. The overall intake of LA therefore increased about 4-fold and the ratio of n-6: n-3 altered from 2.0: 1 to 5.4: 1 on the SoyPreme diet.
|
Surgery
Food but not water was withheld for
20 h before surgery. Access to food was restored after recovery from surgery (
12 h). At 132 day GA anaesthesia was induced with 1 g thiopental sodium BP I.V. (10 ml, 0.1 g ml1, Link Pharmaceuticals, Horsham, UK) and maintained with 2% halothane (Concord Pharmaceuticals Laboratory Ltd, Essex, UK) in O2 (1 l min1) via an endotracheal tube in a closed-circuit system. Once deep anaesthesia had been established, a midline abdominal incision was made and the head of the fetus was exposed through an incision in the uterine wall. The fetal carotid artery and jugular vein were catheterized with polyvinyl catheters (Portex Ltd, Hythe, Kent, UK) and an additional catheter was sutured to the skin of the fetal neck for amniotic pressure monitoring. An ultrasound flow probe (4R, Transonic Systems Inc., Ithaca, NY, USA) was placed around the uncatheterized carotid artery. Following closure of the uterus, three electrodes (Cooner Wire, Chatsworth, CA, USA; 2 for recording, 1 as a reference) were sutured to the myometrium in a triangle approximately 56 cm apart for recording electomyographic (EMG) activity. The catheters, probes and electrodes were exteriorized through a small incision in the ewe's flank and placed in a bag tied to her back. The peritoneum, overlying abdominal muscle and skin were then sutured. A maternal jugular vein catheter was also inserted. All maternal wounds were sprayed with oxytretracycline hydrochloride (Terramycin Pfizer, Eastleigh, Northants, UK) after closure. Vascular catheters were filled with heparinized saline (50 U ml1 heparin, Leo Laboratories Ltd, Princes Risborough, UK; saline 0.9% NaCl) and were flushed daily.
Antibiotics were administered daily to both ewe and fetus over a 5 day post-operative recovery period: Crystapen 300 mg (Britannia Pharmaceuticals Ltd, Redhill, Surrey, UK) to the ewe and 150 mg to the fetus I.V. and 150 mg to the amniotic cavity via the amniotic catheter. Gentamicin (Mayne Pharmaceuticals Plc, Royal Leamington Spa, Warickshire, UK) was administered to the ewe (40 mg I.V.) and amniotic cavity (40 mg) on days 1 and 2 only. Ewes were checked on a daily basis for appropriate defaecation and urination.
Fetal monitoring
Fetal arterial and amniotic pressures were measured using pressure transducers (Capto SP 844, Capto AS, Horten, Norway) connected to a pressure amplifier (NL108, Neurolog, Digitimer, Welwyn Garden City, Herts, UK). Arterial pressure was corrected for amniotic pressure via a Neurolog differential amplifier (NL143). EMG electrode signals were taken via a Neurolog headstage (NL100) to a Neurolog AC preamplifier (NL 104) and filtered (NL125). Processed analog signals (pressure and electrical) from Neurolog equipment were multiplexed to an 8-channel analog-digital converter. The information was then assembled by the central processing unit and recorded onto PowerLab Chart Software (AD Instruments Pty Ltd, Castle Hill, Australia). Data were sampled at a rate of 40 samples a second.
Experimental protocol
EMG recording and labour induction. Amniotic pressure and EMG activity were monitored from surgery to assess uterine activity and to foresee any unplanned preterm births. EMG activity was divided into 2 h sections for analysis. The average number of discrete uterine bursts from each ewe was counted manually within each 2-h period, where a uterine burst was defined as having a minimum duration of 30 s and a minimal interval of 2 min between bursts (see Fig. 1). Any ewes going into labour early were killed by barbiturate overdose for ethical considerations (see below for details).
|
Blood sampling. Blood samples were collected from the fetal carotid artery and maternal jugular catheters post-operatively on 132, 133 and 135 day GA. Frequent blood sampling began on 138 day GA, 32 h before the start of continuous Dex infusion (designated time 0) through to scheduled death that could be up to 44 h into induction. The total amount of blood collected over the 10-day period was 110 ml from the ewe and 53 ml from the fetus. Blood was immediately transferred to chilled 15% ethylenediaminetetraacetic acid (EDTA) treated tubes (Griffiths and Nielson, Billinghurst, Sussex, UK) containing indomethacin (Sigma-Aldrich, UK, 1 mM, in 5% ethanol, 0.9% NaCl, 100 mM NaHCO3 used at a concentration of 100 µl per ml of blood) and centrifuged at 4°C and 1600 g. The plasma was stored at 20°C before subsequent analysis by ELISA or radioimmunoassay.
Fetal and maternal concentrations of 13,14 dihydro-15-keto prostaglandin PGF2
(PGFM) and fetal PGE2 were measured in samples taken daily on 132, 133 and 135 day GA, every 4 h from 10.00 to 22.00 h on 138 day GA (32 to 20 h relative to start of Dex infusion), every 2 h for 6 h either side of the start of Dex infusion (i.e. 6 to +6 h), every 4 h from +16 to +40 h, and a final sample was obtained at scheduled killing.
Oestradiol-17ß and progesterone concentrations in maternal venous samples were measured at 32, 24, 6, 0, +4, +16, +28, +40 h and at killing. The maternal blood samples obtained on 133 and 135 day GA were used to assess maternal metabolic status by measurement of urea, beta-hydroxybutyrate (BHB), insulin and IGF-I concentrations.
A further 0.5 ml fetal arterial blood was collected daily for analysis of pH, blood gases, haematocrit, haemoglobin, glucose and lactate (ABL 700 Series, Radiometer, Copenhagen, Denmark).
Assay procedures
Prostaglandin radioimmunoassays.
PGE2 and PGFM concentrations in the samples were quantified using charcoaldextran-coated radio-immunoassay methods as previously described (Cheng et al. 2001; Robinson et al. 2002). In brief, the tritiated tracers of PGFM (13,14-dihydro-15-keto-[5,6,8,9,11,12,14(n)-3H]-prostaglandin F2
) and PGE2 ([5,6,8,11,12,14,15 (n)-3H]-PGE2) were purchased from Amersham International plc (Amersham, Bucks, UK). The standards of PGFM and PGE2 were supplied by Sigma. The PGFM antiserum was a kind gift from Dr H. Kindahl (Swedish University of Agricultural Sciences, Eskilstuna, Sweden). The antisera to PGE2 was a kind gift from Dr N. L. Poyser (University of Edinburgh, Edinburgh, UK) (Poyser, 1987); the cross-reactivity was 23% with PGE1 and 15% with PGE3. The limit of detection was 1 pg tube1 for PGFM and 2 pg tube1 for PGE2. The intra-assay and interassay coefficients of variation were 7.6% and 14.3% for PGFM and 3.5% and 6.3% for PGE2.
Steroid radio-immunoassays.
Progesterone concentrations were measured in plasma samples after extraction by petroleum ether as previously described (Wathes et al. 1986), using an antiserum kindly donated by Dr M. Sauer (Veterinary Laboratory Agency, Weybridge, Surrey, UK). Oestradiol-17ß concentrations were measured after extraction of 500 µl plasma with 2 ml diethyl ether. The standard was from Sigma, the radiolabel used was [2,4,6,7,16,17-3H]-oestradiol (Amersham International) and the antiserum was from Biogenesis Ltd (Poole, Dorset, UK). Cross reactivity of the antiserum to oestradiol-17
, oestradiol and oestrone was less than 1%. All oestradiol-17ß samples were measured in one assay. The limit of detection was 120 pg ml1 and the intra-assay coefficient of variation was 12%.
Insulin and IGF-I enzyme immunoassays. The sheep insulin assay (Code EIA2339, DRG Diagnostics, Immuno Diagnostic Systems (IDS) Ltd, Tyne and Wear, UK) was a solid phase two-site enzyme immunoassay (ELISA) which was performed according to the manufacturers' instructions. The limit of detection was 0.22 ng ml1. The IGF-I assay used a human immunoenzymometric kit (IEMA) which employs an initial extraction step to remove binding proteins (IDS Ltd). The limit of detection was 0.69 ng ml1. The interassay coefficients of variation for low and high quality control samples were 1.1% and 0.5%, respectively. All samples were measured in one assay. Cross reactivity with IGF-II, insulin and proinsulin was negligible.
Metabolite analysis. Plasma urea concentrations were measured using a Beckman BUN analyser 2 (Beckman Coulter (UK) Ltd, High Wycombe, Bucks (UK)), which uses an enzymatic conductivity rate method via the Beckman conductivity electrode. BHB concentrations were measured on an OPERA (Operationally Enhanced Random Access) analyser (Bayer, Newbury, Berks, UK) using a kinetic enzymatic kit (RANBUT d-3-hydroxybutyrate test kit, Randox Laboratories Ltd, Co Antrim, UK).
Statistical analysis
Results are quoted as the mean ±S.E.M. unless otherwise stated. If data were heterogeneous they were transformed by square root or logarithmic conversion to achieve homogeneity of variance. Fetal blood gas profiles and uterine contractions were analysed by one-way analysis of variance (ANOVA) (SPSS version 12.0, Chicago, IL, USA). Metabolite concentrations between control and LA-supplemented ewes were compared by the unpaired Student's t test. Baseline values (pre-Dex infusion, on days 137 or 138 (between 11:00 and 3:00) for fetal blood pressure and blood flow data and the intervals from the start of Dex treatment until the onset of defined labour were compared between control and LA-supplemented groups by unpaired Student's t test. Maternal and fetal prostaglandin concentrations were analysed by a repeated measures ANOVA via Proc Mixed built in SAS version 8.0 (SAS Institute Inc, Cary NC, USA), where diet, time and their interaction were taken as fixed effects and sheep as the random effect. Data were split by day to look at the effects of diet, time and their interactions. Where significant diet or diettime interactions were found, individual comparisons were made between control and LA-supplemented values using Fisher's LSD test. Changes in PG concentrations between days 132 and 138 were assessed by paired Student's t test. The time to the first rise in oestradiol concentrations above baseline was also assessed by paired Student's t test.
| Results |
|---|
|
|
|---|
All ewes were monitored post-operatively from surgery on 132 day GA. Three of the nine LA-fed ewes went into labour early on 132138 day GA, before Dex infusion had been initiated (Table 2). In ewes which did not labour early, circulating concentrations of fetal PGE2 and PGFM were high post-operatively on 132 day GA but had fallen by 138 day GA (Fig. 2A and B) in both control and LA-supplemented groups. In the LA-supplemented ewes which went into labour early, fetal PGE2 and PGFM concentrations remained high after surgery (Fig. 2A and B) and maternal PGFM concentrations were also higher than in non-labouring ewes on 138 day GA (Fig. 2C).
|
|
In ewes in which labour was induced, basal uterine EMG activity in the 10-h period preceding Dex was significantly higher in control ewes (control 4.1 ± 0.1 bursts per 2 h compared with LA-supplemented 3.5 ± 0.2 bursts per 2 h, P < 0.05). Uterine EMG activity patterns from individual ewes are illustrated in Fig. 3. In both groups, EMG activity remained at a constant baseline until a sharp increase was observed, starting between +18 and +38 h after the start of Dex infusion. The mean time at which the ewes were judged to be in established labour (defined as an increase in EMG activity to twice basal levels for two consecutive 2-h periods) was 7 h earlier in the LA-supplemented ewes (P < 0.05, Table 2) with a range of 3642 h in the control ewes and 2240 h in the LA-supplemented ewes.
|
|
|
Concentrations of BHB, urea, insulin and IGF-I from control and LA-supplemented ewes at 133 and 135 day GA were not significantly different (Table 3). This provides evidence that there was no difference in the nutritional balance of the control and LA-supplemented diets.
|
Following labour induction fetal PaCO2 was higher in fetuses of LA-supplemented ewes at 0 h relative to the start of the Dex infusion (P < 0.05). Glucose was higher in control ewes at the time of killing (P < 0.05). All other results were similar between the two dietary groups (Table 4).
|
| Discussion |
|---|
|
|
|---|
Linoleic acid is the main n-6 PUFA consumed in the human diet. It is metabolized in the body to produce the longer chain PUFAs GLA, DGLA and AA (Sprecher, 2000). The effects of a SoyPreme-supplemented diet providing additional LA (as used in the experiment reported here) on plasma and placental concentrations of PUFA in late pregnant ewes was examined in a companion experiment (Elmes et al. 2004). The high LA diet significantly increased the concentrations of AA in the maternal and fetal plasma phosphatidylcholine (PC) fraction, in fetal allantochorion PC and in the phosphatidylethanolamine fraction of maternal caruncular endometrium. This was accompanied by an increased synthesis of PGE2 and PGF2
in vitro by explants of maternal endometrium and of PGE2 by fetal allantochorion collected on day 138 gestation. These data support the contention that the higher concentrations of 2-series PGs measured in the present experiment were primarily caused by an increased availability of AA. As the concentration of 22: 6 n-3 was also higher in the caruncular endometrium of the SoyPreme-fed ewes (Elmes et al. 2004) it is also possible that a change in the n-6: n-3 ratio may have influenced production of the 2-series PGs in the endometrial tissue.
In addition to the supply of AA as precursor, a critical rate-limiting enzymatic step in prostaglandin synthesis is the availability of COX protein. In both women and sheep, COX-2 gene expression and activity are up-regulated in late gestation, leading to enhanced synthesis of PGF2
(McLaren et al. 1996; Challis et al. 1997; Challis et al. 2002). This increase in PGF2
is widely considered to be a critical step in the labour process; mice lacking the prostaglandin F receptor fail to deliver their pups (Sugimoto et al. 1997) and labour is significantly delayed in ewes treated with selective COX-2 inhibitors (Poore et al. 1999). Furthermore, COX-2 is subject to substrate induction by AA (Parent et al. 2003). In our study the LA diet may thus have raised levels of both substrate and COX-2 which could contribute to the observed approximate doubling of the concentrations of PGE2 and PGF2
in the fetal and maternal circulations. As well as bringing forward the time of labour, changes in PG synthesis would be likely to affect a variety of maturational processes in the fetus, particularly as PGE2 concentrations increased earlier in the fetuses of LA-supplemented ewes. AA is also the precursor for the production of leukotrienes, potent vasoconstrictors that regulate the fetal pulmonary circulation (Heyman, 1999). Patency of the ductus arteriosus is similarly regulated by a balance between vasoconstrictor and vasodilator activities, with circulating concentrations of PGE2 thought to be of key importance (Smith, 1998).
Previous studies have shown that dietary PUFAs can also alter steroid hormone production. For example, cows fed a diet high in the n-6 PUFA LA had decreased levels of progesterone during the luteal phase of the oestrous cycle (Robinson et al. 2002). AA can influence steroidogenic regulatory protein (StAR) (Stocco & Clark, 1996). Inhibition of endogenous AA release inhibited StAR promoter activity, mRNA and protein, whereas exogenous AA reversed all these effects (Wang et al. 2000). In our study, oestradiol concentrations had increased by 16 h post-Dex in the LA-supplemented ewes but not until labour in the controls. Oestradiol-17ß can up-regulate both COX-2 mRNA and protein in maternal pregnant uterine tissues (Wu et al. 2004) and ovariectomized non-pregnant sheep myometrium (Wu et al. 1997). In this study, however, progesterone levels were not different between ewes on the two diets. As the first rise in oestradiol coincided with the increase in maternal PGFM it is not clear which was cause and effect.
Another important finding of this study was that one third of LA-supplemented ewes went into labour early in the absence of Dex induction. Preterm delivery may result from stress during the last third of pregnancy (Mulder et al. 2002). Although the number of ewes which went into labour early in our study was too low for statistical analysis, the data are strongly suggestive that ewes fed an LA-supplemented diet were more susceptible to the stress of surgery. Stress affects the HPA axis, with evidence in rats showing increases in adrenal weight and plasma corticosteroid concentrations and greater sensitivity of the adrenal gland to ACTH (Dallman et al. 1993). Rats fed a high soya diet had higher serum levels of ACTH when compared with control diet animals after 5 min restraint and hippocampal glucocorticoid receptor levels were significantly doubled on the soya diet (Lephart et al. 2003). The sheep in our experiment had raised PGE2 levels as a result of the diet (Fig. 4). Fetal prostaglandin levels were also high following surgery (Fig. 2), possibly due to the associated period of short-term food deprivation which is likely to increase corticotrophic releasing hormone and cortisol levels. In this situation the neuroendocrine events of placentalfetal signalling in late gestation may be sufficiently stimulated to cause preterm delivery.
Preterm birth is the major cause of perinatal morbidity and mortality (Goldenberg et al. 2000; Allen & Harris, 2001). Early preterm labour (< 30 weeks) is most commonly associated with uterine infection during which the production of endotoxins and cytokines stimulates placental prostaglandin release. Infection is, however, rare in late preterm deliveries (3436 weeks) and the underlying causes of such deliveries in humans remain largely unknown. The work we present here indicates that an LA-supplemented diet may increase susceptibility to preterm labour. In addition, if the mother is exposed to either a uterine infection or to a stressor, which activates the HPA axis (Whittle et al. 2001), her enhanced ability to synthesize 2-series prostaglandins may add to the risk of cervical ripening, uterine contractions and membrane rupture. Not all women who start preterm labour necessarily progress through to delivery, but our data suggest that a mother who has recently been consuming a diet rich in vegetable oils is more likely to deliver early.
In conclusion, we have shown that dietary supplementation with LA in late pregnancy resulted in an earlier rise in fetal PGE2 concentrations, a greater increase in fetal and maternal PGFM and an earlier rise in placental oestradiol production. This caused ewes to enter labour earlier.
| References |
|---|
|
|
|---|
Allen
KGD
&
Harris
MA (2001). The role of n-3 fatty acids in gestation and parturition. Exp Biol Med
226, 498506.
Araya J, Rojas M, Fernandez P & Mateluna A (1998). Essential fatty acid content of maternal erythrocyte phospholipids. A study in preterm and full term human newborns. Rev Med Chil 126, 391396.[Medline]
Baguma-Nibasheka
M, Brenna
JT
&
Nathanielsz
PW (1999). Delay of pre-term delivery in sheep by omega-3 long chain polyunsaturates. Biol Reprod
60, 698701.
Challis JRG, Lye SJ & Gibb W (1997). Prostaglandins and parturition. Ann NY Acad Sci 26, 247267.
Challis
JRG, Matthews
SG, Gibb
W
&
Lye
SJ (2000). Endocrine and paracrine regulation of birth at term and pre-term. Endocr Rev
21, 514550.
Challis JRG, Sloboda DM, Alfaidy N, Lye SJ, Gibb W, Patel FA, Whittle W & Newnham JP (2002). Prostaglandins and mechanisms of preterm birth. Reproduction 124, 117.[Abstract]
Cheng Z, Robinson RS, Pushpakumara PG, Mansbridge RJ & Wathes DC (2001). Effect of dietary polyunsaturated fatty acids on uterine prostaglandin synthesis in the cow. J Endocrinol 171, 463473.[Abstract]
Dallman MF, Akana SF, Schribner KA, Dominique Walker C, Strack AM & Sascio CS (1993). Stress feedback and facilitation in the hypothalamo-pituitary-adrenal axis. J Neurondocrinol 134, 327329.
Department of Health (1995). Nutritional Aspects of Cardiovascular Disease. Report on Health and Social Subjects 46, HMSO, London.
Elmes M, Tew P, Cheng Z, Kirkup SE, Abayasekara DRE, Calder PC, Hanson MA, Wathes DC & Burdge GC (2004). The effect of dietary supplementation with linoleic acid to late gestation ewes on the fatty acid composition of maternal and fetal plasma and tissues and the synthetic capacity of the placenta for 2-series prostaglandins. Biochim Biophys Acta 1686, 139147.[Medline]
Goldenberg
RL, Hauth
JC
&
Andrews
WW (2000). Intrauterine infection and preterm delivery. New Engl J Med
342, 15001507.
Heyman MA (1999). Control of pulmonary circulation in the fetus and during the transitional period to air breathing. Eur J Obst Gynec Reprod Biol 84, 127132.[CrossRef]
Holman RT (1971). Essential fatty acid deficiency. Prog Chem Fats Other Lipids 9, 275348.[CrossRef]
Leaver
HA, Lytton
FDC, Dyson
H, Watson
ML
&
Mellor
DJ (1986). The effect of dietary
3 and 6 polyunsaturated fatty acids on gestation, parturition and prostaglandins in intrauterine tissues and the kidney. Prog Lipid Res
25, 143146.[CrossRef]
Lephart ED, Galind E & Hong Bu L (2003). Stress (hypothalamic-pituitary-adrenal axis) and pain response in male rats exposed lifelong to high vs low phytoestrogen diets. Neurosci Lett 342, 6568.[CrossRef][Medline]
Liggins GC & Thorburn GD (1994). Initiation of parturition. In Marshall's Physiology of Reproduction, 4th edn, ed Lamming GE, pp. 8631002. Chapman & Hall, London.
Lye SJ, Ou CW, Teoh TG, Erb G, Stevens Y, Casper R, Patel FA & Challis JRG (1998). The molecular basis of labour and tocolysis. Fetal Maternal Med Rev 10, 121136.[CrossRef]
McLaren WJ, Young IR, Wong MH & Rice GE (1996). Expression of prostaglandin G/H synthase-1 and -2 in amnion and placenta following glucocorticoid-induced labour onset. J Endocrinol 151, 125135.[Abstract]
Mulder EJH, Robles de Medina PG, Huizink AC, Van den Bergh BRH, Buitelaar JK & Visser GHA (2002). Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Human Dev 70, 314.[CrossRef][Medline]
Norman LJ, Lye SJ, Wlodek ME & Chauis JRG (1985). Changes in pituitary responses to synthetic ovine corticotrophin releasing factor in fetal sheep. Can J Physiol Pharmacol 63, 13981403.[Medline]
Office of Population Censuses and Surveys (1990). The Dietary and Nutritional Survey of British Adults. HMSO, London.
Olsen SF, Hanson HS, Sorenson TI, Jensen B, Secher NJ, Sommer S & Krudsen LB (1986). Intake of marine fat, rich in (n-3) polyunsaturated fatty acids may increase birth weight by prolonging gestation. Lancet 2, 367369.[Medline]
Olsen SF, Sorenson JD, Secher NJ, Hedegarrd M, Henriksen TB, Hanson HS & Grant A (1992). Randomized controlled trial of effect of fish oil supplementation on pregnancy duration. Lancet 339, 10031007.[CrossRef][Medline]
Parent
J, Villeneuve
C
&
Fortier
MA (2003). Evaluation of the contribution of cyclooxygenase 1 and cyclooxygenase 2 to the production of PGE2 and PGF2
in epithelial cells from bovine endometrium. Reproduction
126, 539547.[Abstract]
Poore KR, Young IR & Hirst JJ (1999). Efficacy of the selective prostaglandin synthase type 2 inhibitor nimesulide in blocking basal prostaglandin production and delaying glucocorticoid-induced premature labor in sheep. Am J Obstet Gynecol 180, 12441253.[CrossRef][Medline]
Poyser NL (1987). Effects of various factors on prostaglandin synthesis by the guinea-pig uterus. J Reprod Fert 81, 269276.[Abstract]
Reece MS, McGregor JA, Allen KG & Harris MA (1997). Maternal and perinatal long-chain fatty acids: possible roles in preterm birth. Am J Obstet Gynecol 176, 978980.
Rickets AP, Galil AK, Ackland N, Heap RB & Flint AP (1980). Activation by cortocosteroids of steroid matabolizing enzymes in ovine placental explants in vitro. J Endocrinol 85, 457469.[Abstract]
Robinson RS, Pushpakumara PGA, Cheng Z, Peters AR, Abayaskekara DRE & Wathes DC (2002). Effects of dietary polyunsaturated fatty acids on ovarian and uterine function in lactating dairy cows. Reproduction 124, 119131.[Abstract]
Scott JE, Grigsby P, Hirst JJ & Jenkin J (2001). Inhibition of prostaglandin synthesis and its effect on uterine activity during established premature labor in sheep. J Soc Gynecol Invest 8, 266276.[CrossRef][Medline]
Smith
GCS (1998). The pharmacology of the ductus arteriosus. Pharm Rev
50, 3557.
Smith
WL, Garavito
M
&
DeWitt
D (1996). Prostaglandin endoperoxide H synthase (cyclooxygenases) -1 and -2. J Biol Chem
271, 3315733160.
Smith WL, Marnett LJ & DeWitt D (1991). Prostaglandin and thromboxane biosynthesis. Pharmacol Therapeutics 49, 153179.[CrossRef][Medline]
Sprecher H (2000). Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 148, 219231.
Stocco DM & Clark BJ (1996). Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem Pharmacol 51, 19701205.
Sugimoto
Y
et al. (1997). Failure of parturition in mice lacking the prostaglandin F receptor. Science
277, 681683.
Wang H, Walker SW, Mason JI, Morley SD & Williams BC (2000). Role of arachidonic acid metabolism in ACTH-stimulated cortisol secretion by bovine adrenocortical cells. Endocr Res 26, 705709.[Medline]
Wathes DC, Guldenaar SEF, Swann RW, Webb R, Porter DG & Pickering BT (1986). A combined radioimmunoassay and immunocytochemical study of ovarian oxytocin production during the periovulatory period in the ewe. J Reprod Fert 78, 167183.[Abstract]
Whittle
WL, Patel
FA, Alfaidy
N, Holloway
AC, Fraser
M, Gyomorey
S, Lye
SJ, Gibb
W
&
Challis
JRG (2001). Glucocorticoid regulation of human and ovine parturition. The relationship between fetal hypothalamic-pituitary-adrenal axis activation and intrauterine prostaglandin production. Biol Reprod
64, 10191032.
Wu
W, Hong
HX, Zhang
Q, Buchwalder
L
&
Nathanielsz
PW (1997). Regulation of prostaglandin endoperoxide H synthase 1 and 2 by estradiol and progesterone in non pregnant ovine myometrium and endometrium in vivo. Endocrinology
138, 40054012.
Wu
WX, Ma
XH, Coksaygan
T, Chakrabarty
K, Collins
V, Rose
J
&
Nathanielsz
PW (2004). Prostaglandins mediate premature delivery in pregnant sheep induced by estradiol at 121 days of gestational age. Endocrinology
145, 14441452.
| Acknowledgements |
|---|
This article has been cited by other articles:
![]() |
D. C. Wathes, D. R. E. Abayasekara, and R. J. Aitken Polyunsaturated Fatty Acids in Male and Female Reproduction Biol Reprod, August 1, 2007; 77(2): 190 - 201. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |